## Background: Residual renal function (rrf) influences morbidity, mortality and quality of life in chronic dialysis patients. few studies have been published on risk factors for loss of rrf in dialysis patients. these studies were either retrospective, performed in a small number of patients, or e
Predictors of the rate of decline of residual renal function in incident dialysis patients
โ Scribed by Jansen, Maarten A.M. (author);Hart, Augustinus A.M. (author);Korevaar, Johanna C. (author);Dekker, Friedo W. (author);Boeschoten, Elisabeth W. (author);Krediet, Raymond T. (author);Birnie, R. J. (author);Boekhout, M. (author);Boer, W. H. (author);van Buren, M. (author);Buller, H. R. (author);De Charro, F. Th (author);Doorenbos, C. J. (author);Van Dorp, W. T. (author);Van Den Dorpel, M. A. (author);Van Es, A. (author);Feith, G. W. (author);Frenken, L. A.M. (author);Van Geelen, J. A.C.A. (author);Gerlag, P. G.G. (author);Gorgels, J. P.M.C. (author);Grave, W. (author);Hagen, E. C. (author);De Heer, F. (author);Hoorntje, S. J. (author);Huisman, R. M. (author);Jager, K. J. (author);Jie, K. (author);Keur, I. (author);Koning-Mulder, W. A.H. (author);Koolen, M. I. (author);Hovinga, T. K.Kremer (author);Lavrijssen, A. T.J. (author);Luik, A. J. (author);Van Manen, J. G. (author);Van Der Meulen, J. (author);Parlevliet, K. J. (author);Rosman, J. B. (author);Van Der Sande, F. (author);Schonck, M. J.M. (author);Schuurmans, M. M.J. (author);Stege-Man, C. A. (author);Stevens, P. (author);Tijssen, J. G.P. (author);Valentijn, R. M. (author);Vastenburg, G. (author);Verburgh, C. A. (author);Verhagen, C. E. (author);Vincent, H. H. (author);Vos, P. (author);Wolters, J. (author)
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 108 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0085-2538
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The incidence of end-stage renal failure (ESRF) is higher in the Indo-Asian ethnic group as compared to the White. To investigate whether this might be associated with faster rates of progression to ESRF in Indo-Asian diabetic patients, we studied a total of 39 Type 2 diabetic patients, using the De
We recently reported that when diabetic db/db mice, which develop glomerular pathology resembling that in human diabetes mellitus, are treated with monoclonal antibodies (A717) that neutralize the effects of excess glycated albumin, there is an amelioration of mesangial expansion, renal overexpressi